MBRX Stock Earnings: Moleculin Biotech Reported Results for Q4 2023
Source: iQoncept / Shutterstock
Moleculin Biotech (NASDAQ:MBRX) just reported results for the fourth quarter of 2023.
- Moleculin Biotech reported earnings per share of -$5.09.
- The company did not report any revenue for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/mbrx-stock-earnings-moleculin-biotech-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC